Tower Research Capital LLC (TRC) - PMV PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of PMV PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$13,139
+115.3%
2,140
+119.5%
0.00%
Q2 2023$6,104
+67722.2%
975
-45.5%
0.00%
Q1 2023$9
-91.4%
1,788
-85.2%
0.00%
-100.0%
Q4 2022$105
-100.0%
12,092
-51.0%
0.00%
-20.0%
Q3 2022$294,000
+46.3%
24,694
+75.1%
0.01%0.0%
Q2 2022$201,000
+773.9%
14,102
+1199.7%
0.01%
Q1 2022$23,000
-89.7%
1,085
-88.8%
0.00%
-100.0%
Q4 2021$224,000
+113.3%
9,680
+173.6%
0.00%
+33.3%
Q3 2021$105,000
+200.0%
3,538
+241.8%
0.00%
+200.0%
Q2 2021$35,000
-61.5%
1,035
-62.7%
0.00%
-50.0%
Q1 2021$91,000
+237.0%
2,772
+531.4%
0.00%
+100.0%
Q4 2020$27,0004390.00%
Other shareholders
PMV PHARMACEUTICALS INC shareholders Q4 2023
NameSharesValueWeighting ↓
INTERWEST VENTURE MANAGEMENT CO 3,869,911$115,323,00047.76%
Euclidean Capital LLC 2,769,813$82,540,00040.12%
Logos Global Management LP 1,400,000$41,720,0003.01%
Orbimed Advisors 7,330,423$218,447,0002.40%
Boxer Capital, LLC 2,268,236$67,593,0002.36%
PERSONAL CFO SOLUTIONS, LLC 355,342$10,589,0002.17%
Asymmetry Capital Management, L.P. 100,882$3,006,0001.81%
Avoro Capital Advisors LLC 2,925,000$87,165,0001.37%
COMMODORE CAPITAL LP 125,000$3,725,0000.98%
HighVista Strategies LLC 39,777$1,185,0000.78%
View complete list of PMV PHARMACEUTICALS INC shareholders